Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ATAI Life Sciences N.V. - Common Shares (NQ:ATAI)

6.080 +0.120 (+2.01%)
Streaming Delayed Price Updated: 10:10 AM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 660,900
Open 6.000
Bid (Size) 6.070 (11)
Ask (Size) 6.080 (6)
Prev. Close 5.960
Today's Range 5.930 - 6.090
52wk Range 1.040 - 6.300
Shares Outstanding 166,010,476
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Market Momentum: A Diverse Group of Stocks Soar to 52-Week Highs Amidst Shifting Tides
As of mid-October 2025, a compelling and diverse group of companies, spanning utilities, biotechnology, advanced materials, and defense, have seen their stocks reach impressive 52-week highs. This... 
Via MarketMinute
Topics Earnings Economy Intellectual Property
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside
Atai Life Sciences' BPL-003 shows strong Phase 2b results for treatment-resistant depression, with potential $2.5 billion sales by 2035. 
Via Benzinga

Performance

YTD
+280.0%
+280.0%
1 Month
+30.8%
+30.8%
3 Month
+125.2%
+125.2%
6 Month
+328.2%
+328.2%
1 Year
+457.8%
+457.8%

More News

Read More
Alibaba, Lithium Americas And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Via Benzinga
Demystifying ATAI Life Sciences: Insights From 5 Analyst Reviews
Via Benzinga
Why Atai Life Sciences Stock Crushed It on Tuesday
Via The Motley Fool
Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients
Via Benzinga
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
From atai Life Sciences
Via GlobeNewswire
MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI
Via Investor Brand Network
Topics Artificial Intelligence
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
Via Benzinga
Topics Artificial Intelligence
atai Life Sciences Awarded Grant from the National Institutes of Health
From atai Life Sciences
Via GlobeNewswire
atai Life Sciences to Participate in September Investor Conferences
From atai Life Sciences
Via GlobeNewswire
Atai Life Sciences Revenue Jumps 163%
Via The Motley Fool
Topics Intellectual Property
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
From atai Life Sciences
Via GlobeNewswire
This IonQ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
This Atai Life Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday
Via Benzinga
Why Is ATAI Life Sciences Stock Trading Lower On Monday?
Via Benzinga
What's going on in today's pre-market session
Via Chartmill
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
US Stocks Likely To Open Higher As US-EU Ink Trade Deal: Tesla, Palantir, UnitedHealth In Focus
Via Benzinga
Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nucor, Waste Management And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Top movers in Friday's after hours session
Via Chartmill
Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia
From atai Life Sciences
Via GlobeNewswire
Nasdaq Dips 150 Points; US ISM Manufacturing PMI Rises In June
Via Benzinga
Which stocks are experiencing notable movement on Tuesday?
Via Chartmill

Frequently Asked Questions

Is ATAI Life Sciences N.V. - Common Shares publicly traded?
Yes, ATAI Life Sciences N.V. - Common Shares is publicly traded.
What exchange does ATAI Life Sciences N.V. - Common Shares trade on?
ATAI Life Sciences N.V. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for ATAI Life Sciences N.V. - Common Shares?
The ticker symbol for ATAI Life Sciences N.V. - Common Shares is ATAI on the Nasdaq Stock Market
What is the current price of ATAI Life Sciences N.V. - Common Shares?
The current price of ATAI Life Sciences N.V. - Common Shares is 6.080
When was ATAI Life Sciences N.V. - Common Shares last traded?
The last trade of ATAI Life Sciences N.V. - Common Shares was at 10/16/25 10:10 AM ET
What is the market capitalization of ATAI Life Sciences N.V. - Common Shares?
The market capitalization of ATAI Life Sciences N.V. - Common Shares is 1.01B
How many shares of ATAI Life Sciences N.V. - Common Shares are outstanding?
ATAI Life Sciences N.V. - Common Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.